Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

241
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
241
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

355
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
355
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

328
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
328
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

238
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
238
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micro and nanoplastic inhalation during gestation disrupts placentation in the Sprague-Dawley rat.

Research square·2026
Same author

Diet and mycoestrogen exposure in a pregnancy cohort: the Jersey Babies pilot study.

Journal of exposure science & environmental epidemiology·2026
Same author

Polystyrene Nanoplastics Disrupt Mouse Placenta Development in a Sex-Dependent Manner.

bioRxiv : the preprint server for biology·2026
Same author

Nephrotoxicity of Immune Checkpoint Inhibitors in Mice with a Human Immune System.

bioRxiv : the preprint server for biology·2026
Same author

Transporter-Mediated Uptake of Microcystin-LR in Human Trophoblasts: Regulation By Oxygen Concentration and Cell Fusion.

bioRxiv : the preprint server for biology·2026
Same author

ToxiVerse: A Public Platform for Chemical Toxicity Data Sharing and Customizable Predictive Modeling.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.1K

Hierarchical Mechanistic Modeling of Complex Toxicity Endpoints from Public Concentration-Response Data.

Elena Chung1,2, Daniel P Russo2, Lauren M Aleksunes3

  • 1Department of Chemistry and Biochemistry, Rowan University, Glassboro, New Jersey 08028, United States.

Environmental Science & Technology
|January 13, 2026
PubMed
Summary

A new hierarchical model organizes high-throughput screening (HTS) data to predict chemical toxicity. This framework links chemical bioactivity to adverse outcomes, aiding risk assessment and drug discovery.

Keywords:
adverse outcome pathwaysartificial intelligencebig datahierarchical modelinghigh-throughput screeningnew approach methodologiestoxicity prediction

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.6K
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.1K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.6K
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.7K

Area of Science:

  • Computational toxicology
  • Chemical safety assessment
  • Adverse outcome pathway (AOP) research

Background:

  • High-throughput screening (HTS) generates vast chemical toxicity data.
  • Interpreting HTS data for predictive modeling is challenging due to data inconsistencies and varied experimental designs.

Purpose of the Study:

  • To develop a hierarchical mechanistic modeling framework for structuring and interpreting HTS concentration-response data.
  • To create AOP-based models linking chemical bioactivity to adverse outcomes.

Main Methods:

  • Integrated curated data from 455 PubChem assays, mapping to 216 protein targets and 103 WikiPathways.
  • Organized assay data in a biologically layered hierarchy to build AOP-based models.
  • Generated pathway-level toxicity scores by integrating protein activity and pathway perturbations.

Main Results:

  • Developed a framework linking chemical bioactivity to 5 in vivo toxicity endpoints (acute systemic, maternal, developmental, hepatotoxicity).
  • 103 pathways were statistically associated with these toxicity endpoints.
  • The models quantified compound potency and predicted diverse toxicity outcomes.

Conclusions:

  • The hierarchical framework enhances mechanistic interpretability of pathway-level effects from HTS data.
  • Provides a quantitative basis for compound ranking, potency assessment, and hazard prediction.
  • Supports computational toxicology, chemical risk assessment, and early-stage drug discovery.